ENANTA PHARMACEUTICALS INC (ENTA) Insider Trading -- Recent Executive & Director Transactions
8 insiders reported 37 Form 4 transactions for ENANTA PHARMACEUTICALS INC (ENTA) over the past 18 months (most recent 2026-08-10). Recent activity: Rottinghaus Scott T. (Chief Medical Officer) Sell 1,467 shares, Kieffer Tara Lynn (Chief Product Strategy Officer) Sell 3,257 shares, Rottinghaus Scott T. (Chief Medical Officer) Buy 5,225 shares, Rottinghaus Scott T. (Chief Medical Officer) Sell 3,413 shares, Or Yat Sun (Chief Scientific Officer) Buy 1,650 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 1,467 | $19,570 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 3,257 | $46,412 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | Buy | 5,225 | $0 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | Sell | 3,413 | $48,635 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | Buy | 1,650 | $0 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | Buy | 5,225 | $0 |
| 2026-02-13 | Or Yat Sun | Chief Scientific Officer | Sell | 3,413 | $48,635 |
| 2026-02-13 | Luly Jay R. | President and CEO | Buy | 4,800 | $0 |
| 2026-02-13 | Luly Jay R. | President and CEO | Buy | 15,200 | $0 |
| 2026-02-13 | Luly Jay R. | President and CEO | Sell | 6,155 | $87,709 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | Buy | 1,575 | $0 |
| 2026-02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | Buy | 4,987 | $0 |
| 2026-02-13 | Rottinghaus Scott T. | Chief Medical Officer | Buy | 1,650 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | Buy | 1,318 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | Buy | 4,175 | $0 |
| 2026-02-13 | Kowalsky Matthew Paul | Chief Legal Officer | Sell | 1,902 | $27,104 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | Buy | 1,575 | $0 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | Buy | 4,987 | $0 |
| 2026-02-13 | Luu Brendan | Chief Business Officer | Sell | 3,257 | $46,412 |
| 2025-12-05 | Or Yat Sun | Chief Scientific Officer | Sell | 2,390 | $34,010 |
| 2025-12-05 | Capps Kathleen S. | Executive Director of Accounting, Controller (Principal Accounting Officer) | Sell | 323 | $4,596 |
| 2025-12-05 | Trout Harry R. III | Vice President, Finance (Principal Financial Officer) | Sell | 542 | $7,713 |
| 2025-12-05 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 2,106 | $29,968 |
| 2025-12-05 | Luu Brendan | Chief Business Officer | Sell | 1,394 | $19,837 |
| 2025-12-05 | Luly Jay R. | President and CEO | Sell | 4,743 | $67,493 |
Source: SEC Form 4 filings · as of 2026-08-10